An **Arthritis Profile A test** is an extensive diagnostic blood panel designed to evaluate severe joint pain, chronic inflammation, and suspected autoimmune joint disorders. Expanding on basic screenings, this advanced profile typically measures specific autoimmune biomarkers like **Anti-CCP (Cyclic Citrullinated Peptide)**, **Anti-Nuclear Antibodies (ANA)**, and **Rheumatoid Factor (RF)**, along with inflammatory markers like **CRP** and **ESR**. It often incorporates **Uric Acid**, **CBC**, and metabolic assessments to rule out conditions like gout, rheumatoid arthritis, or systemic autoimmune diseases.
Clinicians utilize this comprehensive profile to distinguish between various types of arthritis, assess disease severity, and customize targeted therapeutic strategies.

An **Arthritis Profile B test** is an expanded, multi-parameter diagnostic panel designed to comprehensively evaluate complex joint disorders and autoimmune inflammatory conditions. In addition to core markers like **Rheumatoid Factor (RF)**, **C-Reactive Protein (CRP)**, and **Erythrocyte Sedimentation Rate (ESR)**, Profile B typically incorporates specialized biomarkers such as **Anti-CCP**, **Anti-Nuclear Antibodies (ANA)**, **ASO Titre**, **HLA-B27**, **Complement 3 (C3)**, and **Vitamin D levels**.
Clinicians order this extensive profile for patients presenting with persistent joint pain, morning stiffness, or suspected systemic autoimmune diseases like ankylosing spondylitis or lupus. It provides deep diagnostic insight to differentiate overlapping arthritic conditions and guide targeted therapy.

**Arthritis Profile M** is a comprehensive diagnostic blood panel designed to evaluate joint pain, inflammation, and potential autoimmune disorders. It aids in detecting and managing conditions such as rheumatoid arthritis, gout, osteoarthritis, and other musculoskeletal inflammatory diseases.
This profile typically measures key biomarkers, including Rheumatoid Factor (RF), Anti-CCP, C-Reactive Protein (CRP), Erythrocyte Sedimentation Rate (ESR), Uric Acid, Calcium, and Complete Blood Count (CBC). Together, these tests help identify active systemic inflammation, assess bone health, rule out underlying autoimmune responses, and differentiate specific joint pathologies.
Early testing allows clinicians to deliver targeted treatment, preserve joint mobility, and prevent long-term joint damage.